^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

itraconazole

Company:
Generic mfg.
Drug class:
CYP51A1 inhibitor
Related drugs:
21h
Trial completion • First-in-human
|
itraconazole
5d
Mechanism-guided untargeted-to-targeted lipidomics identifies phosphatidylcholine 38:4 in rat bile as an Abcb4/Mdr2 inhibition marker. (PubMed, Drug Metab Dispos)
Multistage collision-induced dissociation/mass spectrometry3 fragmentation further confirmed the identity as arachidonyl phosphatidylcholine 18:0/20:4. Its rapid and specific decline in the presence of the Mdr2 inhibitor itraconazole offers a potential new tool for early detection of human multidrug resistance protein 3-related liver injury risk during drug development.
Preclinical • Journal
|
ABCB4 (ATP Binding Cassette Subfamily B Member 4)
|
itraconazole
8d
A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine) (clinicaltrials.gov)
P1, N=12, Active, not recruiting, Pfizer | Recruiting --> Active, not recruiting
Enrollment closed
|
itraconazole • prifetrastat (PF-07248144)
8d
Trial initiation date
|
itraconazole
8d
Enrollment open
|
itraconazole • midazolam hydrochloride
18d
A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet (clinicaltrials.gov)
P1, N=28, Recruiting, Guangzhou Lupeng Pharmaceutical Company LTD. | Not yet recruiting --> Recruiting
Enrollment open
|
itraconazole • rifampicin • rocbrutinib (LP-168)
18d
Trial completion
|
metformin • itraconazole
22d
A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults (clinicaltrials.gov)
P1, N=54, Recruiting, Astellas Pharma Global Development, Inc. | Not yet recruiting --> Recruiting
Enrollment open
|
KRAS (KRAS proto-oncogene GTPase)
|
setidegrasib (ASP3082) • itraconazole
23d
New P1 trial
|
itraconazole
24d
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 764198 in the Blood (clinicaltrials.gov)
P1, N=14, Active, not recruiting, Boehringer Ingelheim | Recruiting --> Active, not recruiting
Enrollment closed
|
itraconazole
28d
New P1 trial
|
itraconazole • midazolam hydrochloride
28d
New P1 trial
|
Focus V (anlotinib) • itraconazole